期刊文献+
共找到1,050篇文章
< 1 2 53 >
每页显示 20 50 100
Pharmacological induced target temperature management after cardiac arrest: the capsaicinoids
1
作者 J.Marc Simard Xiaofeng Jia Volodymyr Gerzanich 《Neural Regeneration Research》 SCIE CAS CSCD 2017年第10期1623-1624,共2页
Cardiac or respiratory arrest lasting only a few minutes can inflict grave harm on numerous bodily organs, not least of all, the brain. Neurocognitive deficits, which are often severe and profoundly life altering, rem... Cardiac or respiratory arrest lasting only a few minutes can inflict grave harm on numerous bodily organs, not least of all, the brain. Neurocognitive deficits, which are often severe and profoundly life altering, remain a major source of morbidity among survivors. 展开更多
关键词 Pharmacological induced target temperature management after cardiac arrest:the capsaicinoids
下载PDF
Disease modeling of desmosome-related cardiomyopathy using induced pluripotent stem cell-derived cardiomyocytes
2
作者 Shuichiro Higo 《World Journal of Stem Cells》 SCIE 2023年第3期71-82,共12页
Cardiomyopathy is a pathological condition characterized by cardiac pump failure due to myocardial dysfunction and the major cause of advanced heart failure requiring heart transplantation.Although optimized medical t... Cardiomyopathy is a pathological condition characterized by cardiac pump failure due to myocardial dysfunction and the major cause of advanced heart failure requiring heart transplantation.Although optimized medical therapies have been developed for heart failure during the last few decades,some patients with cardiomyopathy exhibit advanced heart failure and are refractory to medical therapies.Desmosome,which is a dynamic cell-to-cell junctional component,maintains the structural integrity of heart tissues.Genetic mutations in desmo-somal genes cause arrhythmogenic cardiomyopathy(AC),a rare inheritable disease,and predispose patients to sudden cardiac death and heart failure.Recent advances in sequencing technologies have elucidated the genetic basis of cardiomyopathies and revealed that desmosome-related cardiomyopathy is concealed in broad cardiomyopathies.Among desmosomal genes,mutations in PKP2(which encodes PKP2)are most frequently identified in patients with AC.PKP2 deficiency causes various pathological cardiac phenotypes.Human cardiomyocytes differentiated from patient-derived induced pluripotent stem cells(iPSCs)in combination with genome editing,which allows the precise arrangement of the targeted genome,are powerful experimental tools for studying disease.This review summarizes the current issues associated with practical medicine for advanced heart failure and the recent advances in disease modeling using iPSC-derived cardiomyocytes targeting desmosome-related cardiomyopathy caused by PKP2 deficiency. 展开更多
关键词 CARDIOMYOPATHY Advanced heart failure induced pluripotent stem cell-derived cardiomyocytes DESMOSOME Genome editing Gene therapy
下载PDF
Cardiac arrest, stony heart, and cardiopulmonary resuscitation: An updated revisit
3
作者 Ayman El-Menyar Bianca M Wahlen 《World Journal of Cardiology》 2024年第3期126-136,共11页
The post-resuscitation period is recognized as the main predictor of cardiopul-monary resuscitation(CPR)outcomes.The first description of post-resuscitation syndrome and stony heart was published over 50 years ago.Maj... The post-resuscitation period is recognized as the main predictor of cardiopul-monary resuscitation(CPR)outcomes.The first description of post-resuscitation syndrome and stony heart was published over 50 years ago.Major manifestations may include but are not limited to,persistent precipitating pathology,systemic ischemia/reperfusion response,post-cardiac arrest brain injury,and finally,post-cardiac arrest myocardial dysfunction(PAMD)after successful resuscitation.Why do some patients initially survive successful resuscitation,and others do not?Also,why does the myocardium response vary after resuscitation?These ques-tions have kept scientists busy for several decades since the first successful resuscitation was described.By modifying the conventional modalities of resu-scitation together with new promising agents,rescuers will be able to salvage the jeopardized post-resuscitation myocardium and prevent its progression to a dismal,stony heart.Community awareness and staff education are crucial for shortening the resuscitation time and improving short-and long-term outcomes.Awareness of these components before and early after the restoration of circulation will enhance the resuscitation outcomes.This review extensively addresses the underlying pathophysiology,management,and outcomes of post-resuscitation syndrome.The pattern,management,and outcome of PAMD and post-cardiac arrest shock are different based on many factors,including in-hospital cardiac arrest vs out-of-hospital cardiac arrest(OHCA),witnessed vs unwitnessed cardiac arrest,the underlying cause of arrest,the duration,and protocol used for CPR.Although restoring spontaneous circulation is a vital sign,it should not be the end of the game or lone primary outcome;it calls for better understanding and aggressive multi-disciplinary interventions and care.The development of stony heart post-CPR and OHCA remain the main challenges in emergency and critical care medicine. 展开更多
关键词 Cardiac arrest Out-of-hospital cardiac arrest In-hospital cardiac arrest Post-resuscitation Myocardial dysfunction Cardiopulmonary resuscitation Stony heart
下载PDF
Role of induced pluripotent stem cells in diagnostic cardiology 被引量:1
4
作者 Steven B Karch Vittorio Fineschi +6 位作者 Pietro Francia Matteo Scopetti Martina Padovano Federico Manetti Alessandro Santurro Paola Frati Massimo Volpe 《World Journal of Stem Cells》 SCIE 2021年第5期331-341,共11页
Ethical concerns about stem cell-based research have delayed important advances in many areas of medicine,including cardiology.The introduction of induced pluripotent stem cells(iPSCs)has supplanted the need to use hu... Ethical concerns about stem cell-based research have delayed important advances in many areas of medicine,including cardiology.The introduction of induced pluripotent stem cells(iPSCs)has supplanted the need to use human stem cells for most purposes,thus eliminating all ethical controversies.Since then,many new avenues have been opened in cardiology research,not only in approaches to tissue replacement but also in the design and testing of antiarrhythmic drugs.This methodology has advanced to the point where induced human cardiomyocyte cell lines can now also be obtained from commercial sources or tissue banks.Initial studies with readily available iPSCs have generally confirmed that their behavioral characteristics accurately predict the behavior of beating cardiomyocytes in vivo.As a result,iPSCs can provide new ways to study arrhythmias and heart disease in general,accelerating the development of new,more effective antiarrhythmic drugs,clinical diagnoses,and personalized medical care.The focus on producing cardiomyocytes that can be used to replace damaged heart tissue has somewhat diverted interest in a host of other applications.This manuscript is intended to provide non-specialists with a brief introduction and overview of the research carried out in the field of heart rhythm disorders. 展开更多
关键词 Human induced pluripotent stem cells Diagnostic cardiology heart rhythm disorders Microelectrode array Stem cell research Ethical principles
下载PDF
Senescence-like changes induced by expression of p21^(Waf1/Cipl)in NIH3T3 cell line 被引量:9
5
作者 XI CHEN WEI ZHANG +2 位作者 YUN FEI GAO XIAO QIN SU ZHONG HE ZHAI 《Cell Research》 SCIE CAS CSCD 2002年第4期229-233,共5页
P21Waf1/Cip1 is a potent cyclin-dependent kinase inhibitor. As a downstream mediator of p53, p21Waf1/Cip1 involves in cell cycle arrest, differentiation and apoptosis. Previous studies in human cells provided evidence... P21Waf1/Cip1 is a potent cyclin-dependent kinase inhibitor. As a downstream mediator of p53, p21Waf1/Cip1 involves in cell cycle arrest, differentiation and apoptosis. Previous studies in human cells provided evidence for a link between p21Waf1/Cip1 and cellular senescence. While in murine cells, the role of p21Waf1/Cip1 is indefinite. We explored this issue using NIH3T3 cells with inducible p21Waf1/Cip1 expression. Induction of p21Waf1/Cip1 triggered G1 growth arrest, and NIH3T3-p21 cells exhibited morphologic features, such as enlarged and flattened cellular shape, specific to the senescence phenotype. We also showed that p21Waf1/Cip1-transduced NIH3T3 cells expressed β-galactosidase activity at pH 6.0, which is known to be a marker of senescence. Our results suggest that p21Waf1/Cip1 can also induce senescence-like changes in murine cells. 展开更多
关键词 p21Wafl1/Cip1 SENESCENCE inducible expression cell cycle arrest.
下载PDF
Senescence—like changes induced by expression of p21^Waf1/Cip1 in NIH3T3 cell line 被引量:3
6
作者 X1CHEN WEIZHANG 《Cell Research》 SCIE CAS CSCD 2002年第3期229-233,共5页
P21Waf1/Cip1 is a potent cyclin-dependent kinase inhibitor. As a downstream mediator of p53, p21Waf1/Cip1 involves in cell cycle arrest, differentiation and apoptosis. Previous studies in human cells provided evidence... P21Waf1/Cip1 is a potent cyclin-dependent kinase inhibitor. As a downstream mediator of p53, p21Waf1/Cip1 involves in cell cycle arrest, differentiation and apoptosis. Previous studies in human cells provided evidence for a link between p21Waf1/Cip1 and cellular senescence. While in murine cells, the role of p21Waf1/Cip1 is indefinite. We explored this issue using NIH3T3 cells with inducible p21Waf1/Cip1 expression. Induction of p21Waf1/Cip1 triggered G1 growth arrest, and NIH3T3-p21 cells exhibited morphologic features, such as enlarged and flattened cellular shape, specific to the senescence phenotype. We also showed that p21Waf1/Cip1-transduced NIH3T3 cells expressed β-galactosidase activity at pH 6.0, which is known to be a marker of senescence. Our results suggest that p21Waf1/Cip1 can also induce senescence-like changes in murine cells. 展开更多
关键词 P21WAF1/CIP1 SENESCENCE inducible expression cell cycle arrest
下载PDF
Protection of ±500 kV HVDC Double-circuit Converter Station from Lightning Induced Overvoltage 被引量:1
7
作者 DONG Manling YUAN Zhiyong +3 位作者 LI Tianwei ZHAO Xiangen ZHANG Jiaxin HE Junjia 《高电压技术》 EI CAS CSCD 北大核心 2013年第8期2053-2060,共8页
In order to obtain reasonable schemes of arrester in converter stations, the arrester scheme of "Xiluodu-Guangdong HVDC ± 500 kV double circuit transmission" project against lighting induced overvoltage... In order to obtain reasonable schemes of arrester in converter stations, the arrester scheme of "Xiluodu-Guangdong HVDC ± 500 kV double circuit transmission" project against lighting induced overvoltage, which was designed according to the main principle of lightning protection in converter station, is discussed. A calculation of the lighting induced overvoltage in Zhaotong converter station un- der various operation modes is performed with ATP-EMTP software, then the surge arrester configuration of the converter station is decided, and the arrester protection schemes of smoothing reactor and neutral line are studied. It is concluded that additional protection is necessary because of the relatively large gap between protected disconnecting switch and arrester of metallic return transfer bus. Plus, the smoothing reactor (SR) arrester near the valve hall could be removed to improve the scheme’s economic performance. 展开更多
关键词 高压直流输电 过电压保护 换流站 双回路 雷电感应 ATP-EMTP 平波电抗器 避雷器
下载PDF
Pulmonary arterial hypertension confirmed by right heart catheterization following COVID-19 pneumonia: A case report and review of literature
8
作者 Marshaleen Henriques King Ifeoma Chiamaka Ogbuka Vincent C Bond 《World Journal of Respirology》 2023年第1期10-15,共6页
BACKGROUND Pulmonary arterial hypertension(PAH)is a disease of the arterioles resulting in an increased resistance in pulmonary circulation with associated high pressures in the pulmonary arteries,causing irreversible... BACKGROUND Pulmonary arterial hypertension(PAH)is a disease of the arterioles resulting in an increased resistance in pulmonary circulation with associated high pressures in the pulmonary arteries,causing irreversible remodeling of the pulmonary arterial walls.Coronavirus disease 2019(COVID-19)has been associated with development of new onset PAH in the literature leading to symptoms of dyspnea,cough and fatigue that persist in spite of resolution of acute COVID-19 infection.However,the majority of these cases of COVID related PAH were diagnosed using echocardiographic data or via right heart catheterization in mechanically ventilated patients.CASE SUMMARY Our case is the first reported case of COVID related PAH diagnosed by right heart catheterization in a non-mechanically ventilated patient.Right heart catheterization has been the gold standard for diagnosis of pulmonary hypertension.Our patient had right heart catheterization four months after her initial COVID-19 infection due to persistent dyspnea.CONCLUSION This revealed new onset PAH that developed following her infection with COVID-19,an emerging sequela of the infection. 展开更多
关键词 Pulmonary arterial hypertension post COVID-19 infection PAH after COVID-19 infection COVID-19 induced Pulmonary arterial hypertension diagnosed with right heart catheterization Pulmonary arterial hypertension Pulmonary arterial hypertension Right heart catheterization Right heart catheterization COVID-19
下载PDF
目标体温管理对体外心肺复苏患者神经功能结局和出院生存率影响的系统评价 被引量:1
9
作者 王海珍 程鹏飞 +5 位作者 郭璐瑶 王美玲 许赫 顾培培 吴金晶 杨旻斐 《中国急救医学》 CAS CSCD 2024年第2期133-141,共9页
目的系统评价目标体温管理对体外心肺复苏(extracorporeal cardiopulmonary resuscitation,ECPR)患者神经功能结局和出院生存率的影响。方法计算机检索PubMed、Cochrane Library、Elsevier、Web of Science、Ovid、中国知网、万方、Sino... 目的系统评价目标体温管理对体外心肺复苏(extracorporeal cardiopulmonary resuscitation,ECPR)患者神经功能结局和出院生存率的影响。方法计算机检索PubMed、Cochrane Library、Elsevier、Web of Science、Ovid、中国知网、万方、SinoMed、中华医学期刊全文数据库中关于目标体温管理对ECPR患者结局指标影响的文献,检索时限均从建库至2023年6月1日。严格按照纳入排除标准进行筛选,提取资料,评价文献质量,采用RevMan 5.3软件对纳入研究进行Meta分析。结果共纳入8篇研究,包括3687例ECPR患者。与非目标体温管理组比较,目标体温管理未能显著改善患者神经功能结局(OR=1.37,95%CI 0.89~2.13,P=0.16)和出院生存率(OR=0.98,95%CI 0.82~1.15,P=0.77),且两组出血、下肢缺血、肾损伤和感染等ECMO相关并发症发生率差异无统计学意义(OR=1.24,95%CI 0.91~1.68,P=0.17)。结论目标体温管理对ECPR患者的神经结局和出院生存率无显著改善作用,但不会加重ECMO相关并发症的发生。 展开更多
关键词 体外心肺复苏(ECPR) 心脏骤停 目标体温管理 生存率 神经功能 体外膜氧合(ECMO) Meta分析
下载PDF
Dual-chamber pacing confers better myocardial performance and improves clinical outcomes compared to single-chamber pacing
10
作者 Bishav Mohan Akash Batta 《World Journal of Cardiology》 2024年第11期626-631,共6页
The deleterious effects of long term right ventricular pacing are increasingly being recognized today.Current clinical practice favors the implantation of dual-chamber permanent pacemaker which maintains atrioventricu... The deleterious effects of long term right ventricular pacing are increasingly being recognized today.Current clinical practice favors the implantation of dual-chamber permanent pacemaker which maintains atrioventricular synchrony and is associated with better quality of life.However,despite the popular belief and common sense surrounding the superiority of dual-chamber pacing over single chamber pacing,the same has never been conclusively verified in clinical trials.Some observational evidence however,does exists which supports the improved cardiac hemodynamics,lower the rate of atrial fibrillation,heart failure and stroke in dual-chamber pacing compared to single-chamber pacing.In the index study by Haque et al,right ventricular pacing,particularly in ventricular paced,ven-tricular sensed,inhibited response and rate responsive pacemaker adversely im-pacted the left ventricular functions over 9-months compared to dual pacing,dual sensing,dual responsive and rate responsive pacemaker.Although there are key limitations of this study,these findings does support a growing body of evidence reinstating the superiority of dual chamber pacing compared to single chamber pacing. 展开更多
关键词 Permanent pacemaker insertion Pacing induced cardiomyopathy Dualchamber pacemaker Left ventricular ejection fraction Atrial fibrillation heart failure Global longitudinal strain Stroke Cardiovascular outcomes Conduction system pacing
下载PDF
基于血糖优化的早期间断肠内营养在心脏瓣膜置换术后应激性高血糖患者中的应用
11
作者 黄润 张海波 刘萍 《护理学报》 2024年第15期68-72,共5页
目的探讨基于血糖优化干预的早期间断肠内营养方案在心脏瓣膜置换术后合并应激性高血糖患者中的应用效果。方法构建血糖优化干预后的早期间断肠内营养方案,前瞻性分析2022年5月—2023年5月上海市某三级甲等医院心胸外科重症监护室心脏... 目的探讨基于血糖优化干预的早期间断肠内营养方案在心脏瓣膜置换术后合并应激性高血糖患者中的应用效果。方法构建血糖优化干预后的早期间断肠内营养方案,前瞻性分析2022年5月—2023年5月上海市某三级甲等医院心胸外科重症监护室心脏瓣膜置换术后合并应激性高血糖患者158例,按时间先后顺序分为对照组(n=78)和观察组(n=80),对照组采用常规肠内营养与血糖管理方案,观察组采用基于血糖优化干预的早期间断肠内营养方案。比较2组患者血糖管理质量指标及营养相关结局指标。结果实施基于血糖优化管理的早期间断肠内营养方案后,观察组最大血糖波动幅度、胰岛素使用时间及低血糖发生率明显低于对照组(P<0.05),葡萄糖目标范围内时间明显高于对照组,差异具有统计学意义(P<0.05);观察组患者营养相关指标(血清前清蛋白、血红蛋白、7 d热卡达标率)均高于对照组,差异均有统计学意义(P<0.05)。结论基于血糖优化干预的早期间断肠内营养方案可有效改善心脏瓣膜置换术后合并应激性高血糖患者的营养状态,减少血糖波动,提升血糖管理质量,具有一定的科学性和实用性。 展开更多
关键词 早期肠内营养 血糖管理 间断喂养 心脏瓣膜置换术后 应激性高血糖
下载PDF
BlueScreen HC在食品接触材料多组分迁移物遗传毒性检测中的适用性
12
作者 李敏 林珺 +2 位作者 吴炜亮 隋海霞 杨杏芬 《中国药理学与毒理学杂志》 CAS 北大核心 2024年第10期796-806,共11页
目的探讨基于人生长阻滞和DNA损伤诱导45α(GADD45α)基因的遗传毒性高通量筛选体系BlueScreen HC(BSHC)在食品接触材料多组分迁移物遗传毒性检测中的适用性。方法将人GADD45α基因开放阅读框上游2000 bp序列作为启动子,采用分子克隆构... 目的探讨基于人生长阻滞和DNA损伤诱导45α(GADD45α)基因的遗传毒性高通量筛选体系BlueScreen HC(BSHC)在食品接触材料多组分迁移物遗传毒性检测中的适用性。方法将人GADD45α基因开放阅读框上游2000 bp序列作为启动子,采用分子克隆构建入嘌呤霉素和高斯荧光素酶(Gluc)双标记的慢病毒质粒pEZX-LvPG04中,并用慢病毒感染人淋巴母细胞TK6,获得稳转细胞系TK6-Gluc。以甲基磺酸甲酯(MMS,终浓度0,1.56,3.13,6.25,12.5,25.0和50.0 mg·L^(-1))为非代谢活化条件下的阳性物质,环磷酰胺(CTX,终浓度0,0.78,1.56,3.13,6.25,12.5和25.0 mg·L^(-1))为代谢活化条件下的阳性物质,二甲基亚砜(DMSO,终浓度0,0.35,0.69,1.38,2.75,5.5和11.0 g·L^(-1))为阴性物质,分别在非活化和活化条件下验证构建的BSHC。将改性淀粉/聚对苯二甲酸-己二酸丁二醇酯(MS/PBAT)作为研究对象,采用体积分数4%乙酸及10%,20%,50%和95%乙醇作为食品模拟物,40℃、浸泡24 h获得5份MS/PBAT多组分迁移物,并用DMSO作为溶剂复溶得到5份多组分迁移溶液作为受试物。以终浓度为0,0.38,0.76,1.53,3.05,6.10和12.20 g·L^(-1)的不同受试物在活化和非活化2种条件下处理TK6-Gluc细胞。非活化条件下作用48 h;活化条件下,在添加体积分数1%大鼠肝S9代谢活化系统的同时,作用3 h后更换新鲜培养基,继续培养至48 h。处理结束后,采用CCK-8法检测细胞活性,同时采用Secrete-Pair^(TM)Gaussia Luciferase Assay试剂盒检测培养基中Gluc化学发光强度。另外,采用终浓度为3.05和12.20 g·L^(-1)的不同受试物对鼠伤寒沙门氏菌TA98和TA100进行微量波动Ames试验以及对体外培养的中国仓鼠肺细胞CHL进行体外哺乳细胞染色体畸变试验,检测受试物的致突变和染色体畸变作用,与BSHC遗传毒性结果进行对比分析。结果采用BSHC法,将相对细胞活性80%定义为生长抑制的最低有效浓度阈值,实验组相对细胞活性低于溶剂对照组的80%提示化合物引起细胞生长抑制。将实验组相对细胞活性低于溶剂对照组的30%定义为出现细胞毒性,此时将不考虑遗传毒性。在无细胞毒性前提下,活化条件下实验组Gluc化学发光强度大于溶剂对照组的1.8倍时,非活化条件下实验组Gluc化学发光强度大于溶剂对照组的1.5倍时,判定为遗传毒性阳性;反之认为无遗传毒性。与溶剂对照组相比,阴性物质DMSO所有浓度均未产生遗传毒性。非活化条件下,MMS 12.5,25.0和50.0 mg·L^(-1)产生遗传毒性;活化条件下,CTX 6.25,12.5和25.0 mg·L^(-1)产生遗传毒性。非活化条件下,MS/PBAT的95%乙醇迁移物6.10和12.20 g·L^(-1)和MS/PBAT的50%乙醇迁移物12.20 g·L^(-1)组细胞生长抑制,所有处理组均未观察到相对细胞活性低于30%的细胞毒性,且未观察到Gluc高表达,表明5种MS/PBAT多组分迁移物在非活化条件下均未产生遗传毒性。活化条件下,MS/PBAT的95%乙醇迁移物12.20 g·L^(-1)和MS/PBAT的4%乙酸迁移物6.10,12.20 g·L^(-1)组细胞表现出显著的生长抑制,所有处理组均未观察到相对细胞活性低于30%的细胞毒性,且未观察到Gluc高表达,表明5种MS/PBAT多组分迁移物在活化条件下均未产生遗传毒性。微量波动Ames试验结果表明,在活化和非活化条件下,MS/PBAT的5种多组分迁移物3.05和12.20 g·L^(-1)作用于TA98和TA1002种菌株,致突变阳性孔的数量均不超过溶剂对照组的2倍,即均未产生致突变作用;作用于CHL细胞后的细胞染色体畸变率亦均无显著变化。结论初步建立了基于GADD45α基因的遗传毒性高通量筛选方法BSHC,提示可用于食品接触材料多组分迁移物的体外遗传毒性评价,但仍需进一步探索其最低有效浓度,并应用更多种类混合物进行进一步验证。 展开更多
关键词 食品接触材料 多组分迁移物 人生长阻滞和DNA损伤诱导45α基因 遗传毒性评价
下载PDF
TNIP1基因单核苷酸多态性及其mRNA表达水平与老年慢性心力衰竭患者肺部感染的相关性分析
13
作者 许潇 徐华娟 +3 位作者 李洺 严姝瑛 高凤英 陈慧琳 《新疆医科大学学报》 CAS 2024年第4期538-541,547,共5页
目的探讨肿瘤坏死因子诱导蛋白3相互作用蛋白1(TNFAIP3-interacting protein 1,TNIP1)基因单核苷酸多态性及其mRNA表达水平与老年慢性心力衰竭患者肺部感染的相关性。方法选择2019年10月至2022年10月于上海建工医院重症医学科就诊的130... 目的探讨肿瘤坏死因子诱导蛋白3相互作用蛋白1(TNFAIP3-interacting protein 1,TNIP1)基因单核苷酸多态性及其mRNA表达水平与老年慢性心力衰竭患者肺部感染的相关性。方法选择2019年10月至2022年10月于上海建工医院重症医学科就诊的130例老年慢性心力衰竭患者作为研究对象,根据是否于院内发生肺部感染分为感染组(32例)和未感染组(98例)。对TNIP1基因的两个SNP位点rs6889239(T>C)、rs17728338(A>G)进行基因分型,并检测外周血TNIP1基因的mRNA表达水平。结果TNIP1基因rs6889239位点在感染组和非感染组之间的基因型分布以及等位基因频率的差异均无统计学意义(P>0.05);两组的rs17728338位点AA、AG、GG基因型分布比较差异有统计学意义(P<0.05),且感染组等位基因G的频率显著高于未感染组(P<0.05)。相较于未感染组,感染组患者的外周血TNIP1基因mRNA表达水平显著增加,差异有统计学意义(P<0.001)。受试者工作特征(Receiver operating characteristic,ROC)曲线分析结果显示外周血TNIP1基因表达水平预测慢性心力衰竭患者发生肺部感染的灵敏度和特异度分别为71.9%和95.9%。感染组和非感染组TNIP1基因rs6889239位点不同基因型患者的外周血TNIP1基因的表达水平比较差异均无统计学意义(P>0.05),而rs17728338位点不同基因型患者的外周血TNIP1基因表达水平比较差异有统计学意义(P<0.05)。结论TNIP1基因rs17728338表达水平与老年慢性心力衰竭患者发生肺部感染有关。 展开更多
关键词 老年患者 慢性心力衰竭 肺部感染 肿瘤坏死因子诱导蛋白3相互作用蛋白1 单核苷酸多态性
下载PDF
李宜瑞辨治注意缺陷多动障碍经验
14
作者 陈瑶 汤顺莉 +2 位作者 黄秋谷 夏玲玲 刘华 《广州中医药大学学报》 CAS 2024年第2期487-490,共4页
注意缺陷多动障碍是儿童时期常见的以注意力不集中、多动和冲动为特征的精神-心理-行为障碍疾病之一。李宜瑞教授认为,本病系脏腑阴阳失调所致,心脾肾不足乃病机之本,常兼肝亢、痰湿等标证。临证时宜审慎辨证,用药以四君子汤为基础方,... 注意缺陷多动障碍是儿童时期常见的以注意力不集中、多动和冲动为特征的精神-心理-行为障碍疾病之一。李宜瑞教授认为,本病系脏腑阴阳失调所致,心脾肾不足乃病机之本,常兼肝亢、痰湿等标证。临证时宜审慎辨证,用药以四君子汤为基础方,重视健脾,合用龙骨、首乌藤、白芍、石菖蒲、远志、益智、合欢皮、连翘等以增智养神、祛痰开窍,心脾肾同治;同时根据伴随症状进行加减用药,标本兼顾,以调和脏腑阴阳,从而改善注意缺陷多动障碍患儿的注意力、记忆力。 展开更多
关键词 注意缺陷多动障碍 心脾肾不足 四君子汤 健脾 增智养神 祛痰开窍 李宜瑞
下载PDF
血清sTWEAK、sLOX-1与H型高血压合并HFpEF患者颈动脉粥样硬化的关系
15
作者 姜金钟 郭华 +2 位作者 苗维 田守森 田雯艳 《广东医学》 CAS 2024年第10期1226-1230,共5页
目的研究血清可溶性肿瘤坏死因子样凋亡弱诱导因子(sTWEAK)、可溶性凝集素样氧化型低密度脂蛋白受体-1(sLOX-1)与H型高血压合并射血分数保留的心力衰竭(HFpEF)患者颈动脉粥样硬化的关系。方法选取2021年2月至2023年3月沧州中西医结合医... 目的研究血清可溶性肿瘤坏死因子样凋亡弱诱导因子(sTWEAK)、可溶性凝集素样氧化型低密度脂蛋白受体-1(sLOX-1)与H型高血压合并射血分数保留的心力衰竭(HFpEF)患者颈动脉粥样硬化的关系。方法选取2021年2月至2023年3月沧州中西医结合医院收治的161例H型高血压合并HFpEF患者,按是否发生颈动脉粥样硬化分为硬化组与非硬化组。同期选取80例于我院体检的健康的志愿者作为对照组。收集受试者的临床资料,采用酶联免疫吸附法检测血清sTWEAK、sLOX-1水平,比较H型高血压合并HFpEF患者与对照组血清sTWEAK、sLOX-1水平,采用多因素logistic回归分析患者发生颈动脉粥样硬化的影响因素,受试者工作特征(ROC)曲线分析血清sTWEAK、sLOX-1对患者发生颈动脉粥样硬化的预测价值。结果161例患者中65例发生颈动脉粥样硬化,发生率为40.37%(65/161),未发生颈动脉粥样硬化者96例。两组在年龄、吸烟、血脂四项等方面比较,差异有统计学意义(P<0.05)。硬化组与非硬化组血清sTWEAK水平低于对照组,sLOX-1水平高于对照组(P<0.05);且硬化组sTWEAK水平低于非硬化组,sLOX-1水平高于非硬化组(P<0.05)。多因素logistic回归分析显示,HDL-C、sTWEAK、年龄、LDL-C、sLOX-1水平是患者发生颈动脉粥样硬化的影响因素(P<0.05)。ROC曲线显示,血清sTWEAK、sLOX-1联合检测对发生颈动脉粥样硬化的预测曲线下面积(AUC)为0.842,预测效能高于两指标单独检测。结论H型高血压合并HFpEF患者的血清sTWEAK水平下降、sLOX-1水平上升,与颈动脉粥样硬化发生有关,两者联合检测对颈动脉粥样硬化的发生具有一定预测价值。 展开更多
关键词 H型高血压 射血分数保留心力衰竭 颈动脉粥样硬化 可溶性肿瘤坏死因子样凋亡弱诱导因子 可溶性凝集素样氧化型低密度脂蛋白受体-1
下载PDF
肺源性心脏病并发肺动脉高压患者血清β-NGF和TRAIL水平检测在临床诊断及预后评估中的意义
16
作者 唐文慧 应会领 +2 位作者 段静 董卓 尤欣怡 《现代检验医学杂志》 CAS 2024年第4期131-137,共7页
目的探讨肺源性心脏病(pulmonary heart disease,PHD)并发肺动脉高压(pulmonary heart disease,PAH)患者血清β-神经生长因子(β-nerve growth factor,β-NGF)、肿瘤坏死因子相关凋亡诱导配体(tumor necrosis factor-related apoptosis-... 目的探讨肺源性心脏病(pulmonary heart disease,PHD)并发肺动脉高压(pulmonary heart disease,PAH)患者血清β-神经生长因子(β-nerve growth factor,β-NGF)、肿瘤坏死因子相关凋亡诱导配体(tumor necrosis factor-related apoptosis-inducing ligand,TRAIL)表达水平及其在临床诊断及预后评估中的意义。方法采用1∶1病例-对照研究设计选取2019年1月~2022年6月北京市大兴区人民医院86例并发PAH的PHD患者为病例组,86例单纯PHD患者为对照组,进行回顾性分析。将病例组根据肺动脉收缩压(pulmonary arterial systolic pressure,PASP)分为轻度PAH组(n=39)、中度PAH组(n=25)和重度PAH组(n=22),根据出院后一年的结果分为预后良好组(n=75)和预后不良组(n=11)。收集研究对象人口学资料和实验室检查指标,采用酶联免疫吸附(ELISA)法检测血清β-NGF,TRAIL水平。Pearson积矩相关分析β-NGF,TRAIL与PASP的关系,Logistic回归分析PHD患者PAH影响因素,ROC曲线评估β-NGF,TRAIL对PAH的诊断价值,COX比例风险回归分析β-NGF,TRAIL与PHD并发PAH患者预后不良的关系,ROC曲线评估其对预后不良的预测价值。结果与对照组比较,病例组PHD病程长(8.63±1.27年vs 5.49±1.15年),血清β-NGF(26.97±8.25 ng/ml vs 22.14±7.32 ng/ml)和TRAIL(2.83±0.76 ng/ml vs 1.71±0.68 ng/ml)水平升高,差异具有统计学意义(t=17.006,4.064,10.183,均P<0.05)。血清β-NGF,TRAIL对PHD患者PAH有诊断价值,AUC分别为0.842,0.838,二者联合诊断的AUC为0.920,诊断价值高于单一指标(Z=3.416,3.508,均P<0.05)。轻度PAH组、中度PAH组和重度PAH组血清β-NGF(23.26±5.13 ng/ml,27.83±5.57 ng/ml,32.57±6.02 ng/ml),TRAIL(2.24±0.65 ng/ml,2.89±0.71 ng/ml,3.81±0.90 ng/ml)水平依次升高,差异具有统计学意义(F=20.624,31.972,均P<0.05)。病例组血清β-NGF,TRAIL与PASP呈正相关(r=0.673,0.659,均P<0.05)。预后不良组血清β-NGF(36.34±8.05 ng/ml),TRAIL(3.49±1.01 ng/ml)水平高于预后良好组(25.59±7.28 ng/ml,2.73±0.89 ng/ml),差异具有统计学意义(t=4.516,2.604,均P<0.05)。Logistic回归分析结果显示,PHD病程[OR(95%CI):1.784(1.135~2.806)]、β-NGF[OR(95%CI):1.976(1.108~3.523)],TRAIL[OR(95%CI):1.866(1.123~3.101)]是PHD患者发生PAH的独立危险因素(均P<0.05)。多因素COX比例风险回归结果显示,PHD病程[OR(95%CI):1.167(1.082~1.364]、β-NGF[OR(95%CI):1.322(1.134~1.649)],TRAIL[OR(95%CI):1.259(1.087~1.590)]是PHD并发PAH患者预后不良的独立危险因素(均P<0.05)。血清β-NGF,TRAIL可预测PHD并发PAH患者预后不良发生风险,AUC分别为0.863,0.881,二者联合检测的AUC为0.907,诊断价值高于单一指标检测(Z=2.905,3.128,均P<0.05)。结论血清β-NGF和TRAIL升高是PHD患者PAH独立危险因素,并与PAH严重程度有关,早期联合β-NGF和TRAIL检测可提高对PAH的诊断价值及对患者预后不良的预测效果。 展开更多
关键词 Β-神经生长因子 肿瘤坏死因子相关凋亡诱导配体 肺源性心脏病 肺动脉高压
下载PDF
诱导多能干细胞在遗传性心脏疾病模型中的应用与机制 被引量:1
17
作者 马阳光 张雅永 +5 位作者 孟明耀 金志豪 李映明 黄耀萱 韩燊 李亚雄 《中国组织工程研究》 CAS 北大核心 2024年第25期4072-4078,共7页
背景:遗传性心脏病具有较高的患病率及死亡率,至今其发病机制仍未阐明。尽管部分遗传性心脏病已经建立了相应的动物模型,为研究遗传性心脏病的发病机制提供了一定的基础,但是由于物种间的差异等原因显著降低了这些研究结果的价值,因此,... 背景:遗传性心脏病具有较高的患病率及死亡率,至今其发病机制仍未阐明。尽管部分遗传性心脏病已经建立了相应的动物模型,为研究遗传性心脏病的发病机制提供了一定的基础,但是由于物种间的差异等原因显著降低了这些研究结果的价值,因此,需要全新的模型来探索其发生发展过程。目的:综述了目前诱导多能干细胞在构建多种遗传性心脏病模型中的作用和潜在的应用前景。方法:第一作者于2023年1-3月期间应用计算机在Pub Med数据库中检索近13年的相关文献,以“induced pluripotent stem cell,inherited heart disease,congenital heart disease”等为检索词,最终纳入76篇文献进行分析。结果与结论:自2007年诱导多能干细胞从人体体细胞中诱导建立以来,已有许多针对疾病特异性诱导多能干细胞的研究报道。由于疾病特异性诱导多能干细胞能够再现疾病表型,因此有望成为体外疾病建模的一种新研究工具,用于分析发病机制和研制辅助药物。在心血管遗传性疾病的研究方面,从患者特异性诱导多能干细胞分化得到的心肌细胞中含有参与心脏发育异常相关的基因突变,因此,其可作为一种全新的工具研究遗传性心脏病的潜在机制。到目前为止,诱导多能干细胞来源心肌细胞已被广泛用于多种遗传性心脏疾病的分子机制研究,如心脏电生理性疾病、心肌病以及一些综合征性遗传性心脏疾病。 展开更多
关键词 遗传性心脏病 诱导多能干细胞 心肌细胞 疾病模型
下载PDF
消水圣愈汤治疗老年肺源性心脏病临床观察
18
作者 王欢 《中国中医药现代远程教育》 2024年第10期62-64,共3页
目的探讨消水圣愈汤对老年慢性肺源性心脏病(CPHD)患者血栓前状态指标及血清白细胞介素-8(IL-8)和肽素(Copeptin)水平的影响。方法将117例老年CPHD患者随机分为对照组(58例)和试验组(59例)。对照组予常规对症治疗,试验组在对照组的基础... 目的探讨消水圣愈汤对老年慢性肺源性心脏病(CPHD)患者血栓前状态指标及血清白细胞介素-8(IL-8)和肽素(Copeptin)水平的影响。方法将117例老年CPHD患者随机分为对照组(58例)和试验组(59例)。对照组予常规对症治疗,试验组在对照组的基础上予消水圣愈汤治疗,两组均治疗4周。比较两组临床疗效、血栓前状态指标及血清IL-8、Copeptin水平。结果治疗后,试验组总有效率为94.92%(56/59),高于对照组的79.31%(46/58)(P<0.05)。与对照组比较,试验组治疗后血浆黏度、血浆纤维蛋白原(FIB)水平、血清D-二聚体(D-D)、血管性假血友病因子(vWF)、内皮素(ET-1)水平较低,血清IL-8、Copeptin水平较低(P<0.05)。结论消水圣愈汤能明显改善老年CPHD患者血栓前状态,减轻炎症反应,促进心功能恢复,临床疗效显著。 展开更多
关键词 肺胀 慢性肺源性心脏病 老年病 阳虚水泛证 消水圣愈汤 中医药疗法
下载PDF
深低温停循环发展历史与脑保护策略研究进展 被引量:1
19
作者 吕喆 张义和 赵荣 《中国体外循环杂志》 2024年第1期76-80,共5页
深低温停循环将体外循环与低温保护相结合是体外循环发展过程中的一项里程碑式技术。此技术应用于临床以来,已成为心脏大血管外科手术中必不可少的干预方式。因此,本文就其发展历史及其脑保护策略作一综述,为这一技术更好的应用于临床... 深低温停循环将体外循环与低温保护相结合是体外循环发展过程中的一项里程碑式技术。此技术应用于临床以来,已成为心脏大血管外科手术中必不可少的干预方式。因此,本文就其发展历史及其脑保护策略作一综述,为这一技术更好的应用于临床和未来研究提供参考。 展开更多
关键词 深低温停循环 中低温停循环 脑保护 心脏 大血管 手术
下载PDF
The MORC2 p.S87L mutation reduces proliferation of pluripotent stem cells derived from a patient with the spinal muscular atrophy-like phenotype by inhibiting proliferation-related signaling pathways 被引量:1
20
作者 Sen Zeng Honglan Yang +8 位作者 Binghao Wang Yongzhi Xie Ke Xu Lei Liu Wanqian Cao Xionghao Liu Beisha Tang Mujun Liu Ruxu Zhang 《Neural Regeneration Research》 SCIE CAS CSCD 2024年第1期205-211,共7页
Mutations in the microrchidia CW-type zinc finger protein 2(MORC2)gene are the causative agent of Charcot-Marie-Tooth disease type 2Z(CMT2Z),and the hotspot mutation p.S87L is associated with a more seve re spinal mus... Mutations in the microrchidia CW-type zinc finger protein 2(MORC2)gene are the causative agent of Charcot-Marie-Tooth disease type 2Z(CMT2Z),and the hotspot mutation p.S87L is associated with a more seve re spinal muscular atrophy-like clinical phenotype.The aims of this study were to determine the mechanism of the severe phenotype caused by the MORC2 p.S87L mutation and to explore potential treatment strategies.Epithelial cells were isolated from urine samples from a spinal muscular atrophy(SMA)-like patient[MORC2 p.S87L),a CMT2Z patient[MORC2 p.Q400R),and a healthy control and induced to generate pluripotent stem cells,which were then differentiated into motor neuron precursor cells.Next-generation RNA sequencing followed by KEGG pathway enrichment analysis revealed that differentially expressed genes involved in the PI3K/Akt and MAP K/ERK signaling pathways were enriched in the p.S87L SMA-like patient group and were significantly downregulated in induced pluripotent stem cells.Reduced proliferation was observed in the induced pluripotent stem cells and motor neuron precursor cells derived from the p.S87L SMA-like patient group compared with the CMT2Z patient group and the healthy control.G0/G1 phase cell cycle arrest was observed in induced pluripotent stem cells derived from the p.S87L SMA-like patient.MORC2 p.S87Lspecific antisense oligonucleotides(p.S87L-ASO-targeting)showed significant efficacy in improving cell prolife ration and activating the PI3K/Akt and MAP K/ERK pathways in induced pluripotent stem cells.Howeve r,p.S87L-ASO-ta rgeting did not rescue prolife ration of motor neuron precursor cells.These findings suggest that downregulation of the PI3K/Akt and MAP K/ERK signaling pathways leading to reduced cell proliferation and G0/G1 phase cell cycle arrest in induced pluripotent stem cells might be the underlying mechanism of the severe p.S87L SMA-like phenotype.p.S87L-ASO-targeting treatment can alleviate disordered cell proliferation in the early stage of pluripotent stem cell induction. 展开更多
关键词 antisense oligonucleotides cell cycle arrest Charcot-Marie-Tooth disease 2Z induced pluripotent stem cells MAPK/ERK PI3K/Akt PROLIFERATION spinal muscular atrophy-like
下载PDF
上一页 1 2 53 下一页 到第
使用帮助 返回顶部